Anthony Duong
Sr Director, Clinical Operations @Neurocrine Biosciences
Signup · Get unlimited contacts
WORK HISTORY
Sr Director, Clinical Operations @Neurocrine Biosciences
San Diego, CA, US
Responsible for developing strategic and operational plans for Clinical Operations. Develops broader functional strategy development with senior leadership and peers across the organization. Makes decisions for area of responsibility and ensures the effective achievement of objectives and overall management for Clinical Operations team executing Neurocrine\'s clinical studies (all phases). Ensures clinical study activities are conducted in compliance with FDA regulations, EU Directive, ICH guidelines, and are in adherence with corporate and departmental Standard Operations Procedures. A key focus will be on the oversight of CROs, external vendors and internal stakeholders to ensure studies are conducted according to timelines, budgets, and resources to achieve program objectives and corporate goals. Manages the career development of multiple direct reports within the Clinical Operations group.
EDUCATION
Keller Graduate School of Management of DeVry University
Master's degree, Project Management
UC Irvine
Bachelor of Science (B.S.), Biological Science
Keller Graduate School of Management of DeVry University
Master of Business Administration (MBA), Business Administration and Management, General
SKILLS
ABOUT ANTHONY DUONG
Over 30 years of clinical research and development experiences with a wide breadth of clinical research experience in multiple product development and management roles in both early and late phases of clinical development. Diverse and comprehensive clinical research and developmental experience having worked in academia, clinical research sites, CROs, and BioPharma. Diverse therapeutic experience including work in CNS (schizophrenia, major depression, bipolar disorder, stoke, Alzheimer’s Disease, Vascular Dementia, Parkinson’s Disease, Migraine and Cervical Dystonia), Gastrointestinal Disorders (Crohn\'s Disease, Short Bowel Syndrome), Infectious Diseases (HIV, Hepatitis), and Endocrinology (Diabetes). Worked on projects/programs which led to FDA drug approval: Levetiracetam (Keppra)-UBC Pharmaceuticals, Olanzapine (Zyprexa)-Eli Lilly, Quetiapine (Seroquel)-Astra-Zeneca, Donepezil (Aricept)-Eisai, Teduglutide (Gattex/Revestive)-NPS Pharmaceuticals, and Tenofovir disoproxil (Viread)-Gilead.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.